New bioactive secondary metabolites from fungi: 2024.

IF 4.4 2区 生物学 Q1 MYCOLOGY
Mycology Pub Date : 2025-07-11 eCollection Date: 2025-01-01 DOI:10.1080/21501203.2025.2526772
Meiyan Bao, Ying Shi, Xiaoyi Gong, Yutong Guo, Jing Wang, Xiaofei Chen, Ling Liu
{"title":"New bioactive secondary metabolites from fungi: 2024.","authors":"Meiyan Bao, Ying Shi, Xiaoyi Gong, Yutong Guo, Jing Wang, Xiaofei Chen, Ling Liu","doi":"10.1080/21501203.2025.2526772","DOIUrl":null,"url":null,"abstract":"<p><p>Fungi have been recognised as a prolific source of structurally unique secondary metabolites with promising pharmacological properties. This review comprehensively summarises the chemical architectures, bioactivities, and research strategies for new fungal-derived natural products, focusing on representative studies published in 2024. A total of 907 novel fungal-derived compounds are systematically cataloged (isomers are also contained in the total count), including 284 polyketides, 362 terpenoids, 28 steroids, 108 alkaloids, 75 peptides, and 50 glycosides, while highlighting cutting-edge methodologies such as metabolomics-guided discovery platforms and biosynthetic pathway engineering. By establishing connections between chemical novelty and therapeutic value, this review not only provides strategic guidance for fungal chemical diversity exploration but also illuminates their transformative potential in overcoming drug discovery bottlenecks.</p>","PeriodicalId":18833,"journal":{"name":"Mycology","volume":"16 3","pages":"961-987"},"PeriodicalIF":4.4000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12422058/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mycology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21501203.2025.2526772","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MYCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Fungi have been recognised as a prolific source of structurally unique secondary metabolites with promising pharmacological properties. This review comprehensively summarises the chemical architectures, bioactivities, and research strategies for new fungal-derived natural products, focusing on representative studies published in 2024. A total of 907 novel fungal-derived compounds are systematically cataloged (isomers are also contained in the total count), including 284 polyketides, 362 terpenoids, 28 steroids, 108 alkaloids, 75 peptides, and 50 glycosides, while highlighting cutting-edge methodologies such as metabolomics-guided discovery platforms and biosynthetic pathway engineering. By establishing connections between chemical novelty and therapeutic value, this review not only provides strategic guidance for fungal chemical diversity exploration but also illuminates their transformative potential in overcoming drug discovery bottlenecks.

真菌中新的生物活性次生代谢物;2024。
真菌被认为是结构独特的次生代谢物的丰富来源,具有良好的药理特性。本文综述了真菌衍生天然产物的化学结构、生物活性和研究策略,重点介绍了2024年发表的具有代表性的研究成果。共有907种新型真菌衍生化合物(异构体也包含在总数中),包括284种聚酮、362种萜类、28种类固醇、108种生物碱、75种肽和50种糖苷,同时突出了代谢组学引导的发现平台和生物合成途径工程等前沿方法。通过建立化学新颖性与治疗价值之间的联系,本综述不仅为真菌化学多样性的探索提供了战略指导,而且阐明了它们在克服药物发现瓶颈方面的变革潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Mycology
Mycology Medicine-Infectious Diseases
CiteScore
9.10
自引率
0.00%
发文量
18
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信